SOLARA

Vijay Kumar Gupta, SEBI Registered Research Analyst (INH000020226) 📌 My View (Short-Term): The stock is consolidating near a critical resistance zone after a powerful breakout. Momentum looks healthy, supported by solid volumes and improving fundamentals. 📊 Chart Insight: Trading above Ichimoku cloud with a bullish bias. Price hovering in the Fair Value Gap zone; yet to clear upper resistance. CCI near +98 indicates moderate bullish momentum without overextension. TTM Squeeze shows fading histogram bars – possible pause before fresh move. Volume consolidation suggests healthy digestion of gains. 🧠 Fundamentals & News Flow: Solara is one of India’s leading API manufacturers, focusing on chronic therapy segments like pain management and inflammation. Recent performance boosted by operational turnaround and restructuring efforts post its merger phase. Q4FY25 Results Highlights: Revenue growth of ~15% YoY PAT nearly tripled to ₹41 Cr vs ₹15 Cr YoY Gross margins expanded significantly due to better product mix Debt reduction and working capital efficiency remain key positives Management commentary hints at stronger export orders and improved utilization in FY26. 🧩 Key Themes Driving Sentiment: FII/DII interest returning in niche pharma plays Focus on API de-risking by global clients helping Indian manufacturers Financial deleveraging and margin expansion improving investor confidence | Compliance: SEBI INH000020226 | This is market opinion, not investment advice.